limonene has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adriana Estrella, GR; Alberto, HL; Azucena, CV; Francisco Javier, LM; María Eva, GT; María Guadalupe, VD; Noé, AV; Sandra, OS | 1 |
| Sun, Z; Yan, J; Yu, L | 1 |
2 other study(ies) available for limonene and Colitis Gravis
| Article | Year |
|---|---|
Limonene from Agastache mexicana essential oil produces antinociceptive effects, gastrointestinal protection and improves experimental ulcerative colitis.
Topics: Agastache; Analgesics; Animals; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Limonene; Male; Mice; Mice, Inbred BALB C; Monoterpenes; Oils, Volatile; Pain; Rats; Rats, Wistar; Sulfasalazine | 2021 |
D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Cyclohexenes; Cyclooxygenase 2; Dinoprostone; Intestinal Mucosa; Limonene; Male; MAP Kinase Signaling System; Nitric Oxide Synthase Type II; Rats, Sprague-Dawley; Terpenes | 2017 |